GTx Submits New Drug Application for Toremifene 80 mg for the … – WELT ONLINE

Prevention — By on December 30, 2008 at 7:22 am
GTx Submits New Drug Application for Toremifene 80 mg for the
WELT ONLINE, Germany – 27 minutes ago
"If approved, toremifene 80 mg could become the first cancer care agent for the prevention of fractures in men receiving ADT.” Ipsen Group has licensed
GTx Submits NDA for Toremifene 80 mg for Prevention of Bone RTT News
all 7 news articles

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback